60 related articles for article (PubMed ID: 17127264)
1. Phytate acts as an inhibitor in formation of renal calculi.
Grases F; Isern B; Sanchis P; Perello J; Torres JJ; Costa-Bauza A
Front Biosci; 2007 Jan; 12():2580-7. PubMed ID: 17127264
[TBL] [Abstract][Full Text] [Related]
2. SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels.
Perelló J; Gómez M; Ferrer MD; Rodríguez NY; Salcedo C; Buades JM; Pérez MM; Torregrosa JV; Martín E; Maduell F
J Nephrol; 2018 Apr; 31(2):287-296. PubMed ID: 29350348
[TBL] [Abstract][Full Text] [Related]
3. Theobromine inhibits uric acid crystallization. A potential application in the treatment of uric acid nephrolithiasis.
Grases F; Rodriguez A; Costa-Bauza A
PLoS One; 2014; 9(10):e111184. PubMed ID: 25333633
[TBL] [Abstract][Full Text] [Related]
4. Estimated Phytate Intake Is Associated with Bone Mineral Density in Mediterranean Postmenopausal Women.
Sanchis P; Prieto RM; Konieczna J; Grases F; Abete I; Salas-Salvadó J; Martín V; Ruiz-Canela M; Babio N; García-Gavilán JF; Goday A; Costa-Bauza A; Martínez JA; Romaguera D
Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049631
[TBL] [Abstract][Full Text] [Related]
5. Phytate Intake, Health and Disease: "Let Thy Food Be Thy Medicine and Medicine Be Thy Food".
Pujol A; Sanchis P; Grases F; Masmiquel L
Antioxidants (Basel); 2023 Jan; 12(1):. PubMed ID: 36671007
[TBL] [Abstract][Full Text] [Related]
6. Current material engineering strategies to prevent catheter encrustation in urinary tracts.
Yao Q; Wu C; Yu X; Chen X; Pan G; Chen B
Mater Today Bio; 2022 Dec; 16():100413. PubMed ID: 36118951
[TBL] [Abstract][Full Text] [Related]
7. Effect of phytate on hypercalciuria secondary to bone resorption in patients with urinary stones: pilot study.
Guimerà J; Martínez A; Bauza JL; Sanchís P; Pieras E; Grases F
Urolithiasis; 2022 Dec; 50(6):685-690. PubMed ID: 36087116
[TBL] [Abstract][Full Text] [Related]
8. Effect of phytate on crystallization on ureteral stents and bacterial attachment: an in vitro study.
Calvó P; Mateu-Borras M; Costa-Bauza A; Albertí S; Grases F
Urolithiasis; 2022 Dec; 50(6):737-742. PubMed ID: 36064981
[TBL] [Abstract][Full Text] [Related]
9. Inositol hexaphosphate-induced cellular response in myeloid leukemia cells is mediated by nicotinamide adenine dinucleotide phosphate oxidase activation.
Kato A; Hirakawa Y; Hiraoka W
Fujita Med J; 2019; 5(4):98-103. PubMed ID: 35111510
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Protective Effect of Phytate in Bone Decalcification Related-Diseases.
Sanchis P; López-González ÁA; Costa-Bauzá A; Busquets-Cortés C; Riutord P; Calvo P; Grases F
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445019
[TBL] [Abstract][Full Text] [Related]
11. Dietary and lifestyle factors for primary prevention of nephrolithiasis: a systematic review and meta-analysis.
Lin BB; Lin ME; Huang RH; Hong YK; Lin BL; He XJ
BMC Nephrol; 2020 Jul; 21(1):267. PubMed ID: 32652950
[TBL] [Abstract][Full Text] [Related]
12. Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial.
Torrecilla C; Fernández-Concha J; Cansino JR; Mainez JA; Amón JH; Costas S; Angerri O; Emiliani E; Arrabal Martín MA; Arrabal Polo MA; García A; Reina MC; Sánchez JF; Budía A; Pérez-Fentes D; Grases F; Costa-Bauzá A; Cuñé J
BMC Urol; 2020 Jun; 20(1):65. PubMed ID: 32503502
[TBL] [Abstract][Full Text] [Related]
13. A Pilot Randomized Crossover Trial Assessing the Safety and Short-Term Effects of Walnut Consumption by Patients with Chronic Kidney Disease.
Sanchis P; Molina M; Berga F; Muñoz E; Fortuny R; Costa-Bauzá A; Grases F; Buades JM
Nutrients; 2019 Dec; 12(1):. PubMed ID: 31881702
[TBL] [Abstract][Full Text] [Related]
14. Key Aspects of Myo-Inositol Hexaphosphate (Phytate) and Pathological Calcifications.
Grases F; Costa-Bauza A
Molecules; 2019 Dec; 24(24):. PubMed ID: 31817119
[TBL] [Abstract][Full Text] [Related]
15. Which Diet for Calcium Stone Patients: A Real-World Approach to Preventive Care.
D'Alessandro C; Ferraro PM; Cianchi C; Barsotti M; Gambaro G; Cupisti A
Nutrients; 2019 May; 11(5):. PubMed ID: 31137803
[TBL] [Abstract][Full Text] [Related]
16. Urinary phytate concentration and risk of fracture determined by the FRAX index in a group of postmenopausal women.
Gonzalez AAL; Grases F; Mari B; Tomas-Salva M; Rodriguez A
Turk J Med Sci; 2019 Apr; 49(2):458-463. PubMed ID: 30862150
[TBL] [Abstract][Full Text] [Related]
17. Potential thermodynamic and kinetic roles of phytate as an inhibitor of kidney stone formation: theoretical modelling and crystallization experiments.
Fakier S; Rodgers A; Jackson G
Urolithiasis; 2019 Dec; 47(6):493-502. PubMed ID: 30767040
[TBL] [Abstract][Full Text] [Related]
18. Functional eubacteria species along with trans-domain gut inhabitants favour dysgenic diversity in oxalate stone disease.
Suryavanshi MV; Bhute SS; Gune RP; Shouche YS
Sci Rep; 2018 Nov; 8(1):16598. PubMed ID: 30413731
[TBL] [Abstract][Full Text] [Related]
19. First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification.
Perelló J; Joubert PH; Ferrer MD; Canals AZ; Sinha S; Salcedo C
Br J Clin Pharmacol; 2018 Dec; 84(12):2867-2876. PubMed ID: 30280390
[TBL] [Abstract][Full Text] [Related]
20. Phytate Decreases Formation of Advanced Glycation End-Products in Patients with Type II Diabetes: Randomized Crossover Trial.
Sanchis P; Rivera R; Berga F; Fortuny R; Adrover M; Costa-Bauza A; Grases F; Masmiquel L
Sci Rep; 2018 Jun; 8(1):9619. PubMed ID: 29941991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
